Protein drug formulation: Converting biologically active substances into stable pharmaceutical products

Abstract

The clinical success of protein therapy depends on transforming inherently unstable, biologically active macromolecules into robust pharmaceutical products with acceptable shelf life and safety profiles. Unlike small-molecule drugs, proteins are susceptible to multiple physical and chemical degradation pathways - including aggregation, deamidation, oxidation, and denaturation - which can compromise efficacy and trigger immunogenicity. This abstract describes the core challenges and strategic approaches in protein formulation development. Successful formulation requires a deep understanding of conformational stability and protein degradation kinetics under various stress conditions (thermal, mechanical, and interfacial). Key formulation parameters include the choice of buffer systems to maintain optimal pH (typically 5-7), the addition of stabilizers such as sugars (trehalose, sucrose) and polyols for preferential hydration of the protein surface, and the inclusion of surfactants (polysorbate 20 or 80) to prevent adsorption and aggregation at interfaces. For liquid formulations, optimization of ionic strength and the use of antioxidants (e.g., methionine) mitigate chemical degradation. When the stability of liquid formulations is compromised, lyophilization or spray drying is applied, enabling stabilization and formulation into amorphous solid forms, although these require careful selection of excipients (bulking agents, lyoand cryoprotectants) and cycle optimization to preserve the native structure during freezing and drying. High-concentration formulations (>100 mg/ml) required for subcutaneous administration impose additional challenges in terms of viscosity control and reversible self-association. By integrating analytical tools (size-exclusion chromatography, dynamic light scattering, FTIR, and nano-DSF) with rational excipient design, stable, safe, and effective protein drugs can be reliably achieved.